No benefit in prolonged anticoagulation in cancer patients without residual venous thrombosis
1. Cancer patients treated with 6 months of low molecular weight heparin (LMWH) for first-time DVT with no residual clot do ...
1. Cancer patients treated with 6 months of low molecular weight heparin (LMWH) for first-time DVT with no residual clot do ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Ultrasonography ...
1. Current rates of venous thromboembolism (VTE) prophylaxis during vaginal delivery hospitalizations are low, with patients having a history of ...
1. Apart from the increased thrombosis in 3 month follow up noted with the unfractionated heparin (UFH)-vitamin K antagonist combination, ...
Image: PD 1. A retrospective review of US hospital discharge records from 1999-2009 showed an increase of in-hospital venous thromboemobolism ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.